André D’Hoore

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

Mucosal healing in inflammatory bowel diseases: a systematic review

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

The gut microbiota and host health: a new clinical frontier

Effect of Laparoscopic Surgery on Quality of Life in Ulcerative Colitis

Cytokines in inflammatory bowel disease

Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis

Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis

Role of endoscopy in predicting the disease course in inflammatory bowel disease

Conventional Medical Management of Inflammatory Bowel Disease

Review article: monitoring of immunomodulators in inflammatory bowel disease

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second‐line medical therapy or surgery

Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study

Myasthenia Gravis

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis

5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis

Review article: infliximab therapy for inflammatory bowel disease – seven years on

Intestinal homeostasis and its breakdown in inflammatory bowel disease

Ulcerative Colitis

European evidence based consensus for endoscopy in inflammatory bowel disease

Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain

Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study

Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

The Human Intestinal Microbiome in Health and Disease

Inflammatory bowel disease: clinical aspects and established and evolving therapies

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

Crohn's disease

Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria

Male Issues of the Ileal Pouch

How Rapidly Should Remission Be Achieved?

The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study

Inflammatory bowel disease: cause and immunobiology

Inflammatory Bowel Disease

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Ciclosporin use in acute ulcerative colitis

Colorectal cancer

Biological Therapies for Inflammatory Bowel Diseases

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Inflammation and Colon Cancer

Microbial Influences in Inflammatory Bowel Diseases

What role do antibiotics have in the treatment of IBD?

Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study

Ulcerative colitis

6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party

Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Crohn's disease

Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review

Review article: remission rates achievable by current therapies for inflammatory bowel disease

Basiliximab for the treatment of steroid‐resistant ulcerative colitis: further experience in moderate and severe disease

The role of antibiotic and probiotic therapies in current and future management of inflammatory Bowel disease

Intestinal mucosal barrier function in health and disease

Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial

Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways

Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease

Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis

Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases

Neuroplasticity and dysfunction after gastrointestinal inflammation

Medical therapy for ulcerative colitis 2004

Ulcerative colitis

Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection

Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study

Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

Progress in treatments for colorectal cancer peritoneal metastases during the years 2010–2015. A systematic review

Evolving knowledge and therapy of inflammatory bowel disease

Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis

Clinical implications of mucosal healing for the management of IBD

Video-assisted thoracoscopic surgery for patients with pulmonary coccidioidomycosis

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

Microbial host interactions in IBD: Implications for pathogenesis and therapy

Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

Epidemiology and Natural History of Inflammatory Bowel Diseases

Optimization of conventional therapy in patients with IBD

Mucosal Healing in Crohnʼs Disease

Macrophage Cytokines: Involvement in Immunity and Infectious Diseases

European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations

Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Biologic agents for IBD: practical insights

Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease

Management of Crohn's Disease in Adults

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo‐controlled trial with rifaximin

Guidelines for the management of inflammatory bowel disease in adults

DLS and zeta potential – What they are and what they are not?

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

The gut microbiota shapes intestinal immune responses during health and disease

The human microbiome: at the interface of health and disease

An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

Review article: the natural history of postoperative Crohn's disease recurrence

Randomised clinical study: discrepancies between patient‐reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis

Gut Microbiota in Health and Disease

Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

Photo-fluorescent and magnetic properties of iron oxide nanoparticles for biomedical applications

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population‐based IBDSL cohort

[Crohn's disease].

[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Workshop Report: Prevention of Postoperative Recurrence in Crohn's Disease

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

Inflammatory Bowel Disease

Review article: integrating budesonide‐MMX into treatment algorithms for mild‐to‐moderate ulcerative colitis

A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis

Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy

European evidence-based Consensus on the management of ulcerative colitis: Current management

Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and future

Management of acute severe colitis

Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease

Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery

Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genes

The Value of Myenteric Plexitis to Predict Early Postoperative Crohn’s Disease Recurrence

Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial

The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study

Long-term outcome after infliximab for refractory ulcerative colitis

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial management, data analysis, and writing the paper. Maja Noman had a major contribution in the clinical ambulatory follow-up of the patients in the trial. Martin Hiele followed cyclosporine levels and adjusted drug doses of patients in the trial and provided statistical advice. Katrien Asnong was the study coordinator and had a major share in data analysis. Joris Arts analyzed safety data and followed patients clinically during the trial. Andre D’Hoore and Freddy Penninckx performed the surgical interventions in patients failing the trial and substantially contributed in evaluating patients for colectomy.

Major pulmonary resections: Pneumonectomies and lobectomies

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

Mechanical Bowel Preparation or Not? Outcome of a Multicenter, Randomized Trial in Elective Open Colon Surgery